Beranda › Kanker (semua jenis) › Minnesota › Rochester
Uji klinis Kanker (semua jenis) di Rochester, MN
30 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Rochester (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Menerima pesertaFase 3
- Investigative Site, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Menerima pesertaStudi observasional
- Mayo Clinic Rochester, Rochester
A Study of JNJ-1761981 in Participants With Solid Tumors
Menerima pesertaFase 1
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Menerima pesertaFase 3
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- Mayo Clinic, Rochester
Statins to Prevent Cancer Associated Blood Clots
Menerima pesertaFase 4
- Mayo Clinic, Rochester
Biomarkers of Resiliency In Childhood Cancer Surgery
Menerima pesertaStudi observasional
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Menerima pesertaFase 1/2
- Mayo Clinic Rochester, Rochester
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Menerima pesertaStudi observasional
- Mayo Clinic Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Menerima pesertaFase 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Mayo Clinic in Rochester, Rochester
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Menerima pesertaFase 3
- Mayo Clinic, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Mayo Clinic, Rochester
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Mayo Clinic in Rochester, Rochester
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- Mayo Clinic - Rochester /ID# 251164, Rochester
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Menerima pesertaFase 2
- Mayo Clinic-Rochester /ID# 273508, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Mayo Clinic Rochester, Rochester
Patient Derived Preclinical Models
Menerima pesertaStudi observasional
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Menerima peserta
- Mayo Clinic, Rochester
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- Mayo Clinic Rochester, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- Mayo Clinic, Rochester
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Menerima pesertaFase 1/2
- Mayo Clinic, Rochester
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
Menerima pesertaStudi observasional
- Mayo Clinic in Rochester, Rochester
Multi-Cancer Detection Observational Cohort Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Mayo Clinic in Rochester, Rochester
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Menerima pesertaFase 2
- Mayo Clinic, Rochester
Primary Tumor Research and Outcomes Network
Menerima pesertaStudi observasional
- Mayo Clinic, Rochester
Testicular Tissue Cryopreservation in Children
Menerima peserta
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Mayo Clinic, Rochester
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Rochester
- Kanker Payudara42 studi
- Kanker Paru Non-Sel Kecil37 studi
- Kanker Metastatik31 studi
- Kanker Kolorektal29 studi
- Kanker Ovarium29 studi
- Mieloma Multipel24 studi
- Kanker Prostat22 studi
- Gagal Jantung22 studi
- Kanker Pankreas22 studi
- Kanker Paru20 studi
- Kanker Endometrium20 studi
- Leukemia Limfositik Kronis19 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.